Top Growth Trends in the Epkinly Market: Key Insights and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the epkinly market right now?
The size of the epkinly market has seen a rise of XX (HCAGR) over recent times. Anticipated to grow from a size of $XX million in 2024 to $XX million in 2025, it exhibits a compound annual growth rate (CAGR) of XX%. The prominent growth during the historical period can be traced back to the surge in healthcare consciousness, heightened support from regulatory bodies, a susceptible pediatric demographic, a rise in incidences of cancer, and an uptick in lung cancer occurrences.
How fast Is the epkinly market expected to grow, and what’s its future value?
The market size of epkinly is projected to witness XX (FCAGR) in the upcoming years, attaining a worth of $XX million in 2029 with a CAGR of XX%. This surge in the projected period can be traced back to a rise in R&D endeavors, an escalation of advanced therapy usage, heightened awareness of healthcare, more investment inflows, and the growing acceptance of high-end therapies. The prediction period is charmed with significant trends such as the launch of new drugs, an increase in the R&D pursuits for non-Hodgkin lymphoma treatment, the introduction of innovative treatment possibilities, technological breakthroughs, and advancements in technology.
Get your epkinly market report here!
https://www.thebusinessresearchcompany.com/report/epkinly-global-market-report
What are the leading drivers of growth in the epkinly market?
The future expansion of the epkinly market is projected to be propelled by the increasing demand for targeted therapies. Such therapies are particular treatments that obstruct certain molecules instrumental in disease progression, especially in cancers, and they produce fewer side effects than conventional treatments. Due to their potential to offer more tailored and effective treatments with minimal side effects, targeted therapies are witnessing an increase in popularity. Epkinly (epcoritamab) is used in targeted therapy for treating refractory or relapsed B-cell non-Hodgkin lymphoma, as it binds to CD3 on T cells and CD20 on B cell, consequently instructing the immune system to eliminate cancerous B cells. The National Health Service, a UK government department, reported in October 2024 that 14.5% of HRT (hormone replacement therapy) items in 2023/24 were related to an HRT prepayment certificate (PPC) prescription. By June 2024, this ratio had escalated to 21%, in contrast to the 9.7% recorded in June 2023. Consequently, the upward trend in demand for targeted therapies is fueling the growth of the epkinly market.
What are the key segments defining the epkinly market?
The epkinly market covered in this report is segmented –
1) By Indication: Relapsed Or Refractory Diffuse Large B-Cell Lymphoma (DLBCL), High-Grade B-Cell Lymphoma (HGBL), Indolent Lymphoma
2) By Route Of Administration: Intravenous (IV), Subcutaneous (SC)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20060&type=smp
Who are the key players steering the development of the epkinly market?
Major companies operating in the epkinly market include AbbVie Inc.; Genmab A/S.
What emerging trends are influencing the growth of the epkinly market?
Significant trends in the Epkinly market center around receiving regulatory consent for innovative therapies like bispecific antibody treatments, which aim to broaden and improve treatment efficacy. This type of immunotherapy involves antibodies custom-engineered to concurrently bind to two different antigens or targets. For instance, in June 2024, the biotech company based in the USA, AbbVie Inc., acquired FDA approval for EPKINLY (epcoritamab-bysp), making it the pioneer in bispecific antibody treatment for adults enduring relapsed or resistant follicular lymphoma (FL) after two or more systemic therapy lines. This breakthrough treatment targets CD20 and CD3 and actively involves the immune system, resulting in an impressive overall response rate of 82% in clinical trials. Provided subcutaneously with a step-up dosing regimen, EPKINLY opens up a fresh avenue for patients with limited options. This green light symbolizes a significant step forward in managing follicular lymphoma, bringing hope for improved outcomes for patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20060
Which regions are most influential in expanding the epkinly market?
North America was the largest region in the epkinly market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the epkinly market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Diffuse Large B-Cell Lymphoma Therapeutics Global Market Report 2025
Follicular Lymphoma Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/follicular-lymphoma-treatment-global-market-report
Mantle Cell Lymphoma Therapeutics Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
